aluates Reports

$ 0.0

Automative

Global Marburg Hemorrhagic Fever Drug Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-29P7077

Global Marburg Hemorrhagic Fever Drug Market Insights Forecast to 2028

BUY CHAPTERS

Global Marburg Hemorrhagic Fever Drug Market Research Report 2025

Code: QYRE-Auto-29P7077

Report

September 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GlaxoSmithKline PLC

Immunovaccine

Integrated BioTherapeutics Inc

Sarepta Therapeutics Inc

Tekmira Pharmaceuticals Corp.

Vaxart Inc.

Marburg Hemorrhagic Fever Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Marburg Hemorrhagic Fever Drug Market

The global market for Marburg Hemorrhagic Fever Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Marburg Hemorrhagic Fever Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Marburg Hemorrhagic Fever Drug.

The Marburg Hemorrhagic Fever Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Marburg Hemorrhagic Fever Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Marburg Hemorrhagic Fever Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Marburg Hemorrhagic Fever Drug Market Report

Report Metric	Details
Report Name	Marburg Hemorrhagic Fever Drug Market
CAGR	5%
Segment by Type	Marburg Vaccine AVI-7288 TKM-Marburg Others
Segment by Application	Clinic Hospital Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	GlaxoSmithKline plc, Immunovaccine, Inc., Integrated BioTherapeutics, Inc., Sarepta Therapeutics, Inc., Tekmira Pharmaceuticals Corp., Vaxart, Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Marburg Hemorrhagic Fever Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Marburg Hemorrhagic Fever Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Marburg Hemorrhagic Fever Drug Market report?

Ans: The main players in the Marburg Hemorrhagic Fever Drug Market are GlaxoSmithKline plc, Immunovaccine, Inc., Integrated BioTherapeutics, Inc., Sarepta Therapeutics, Inc., Tekmira Pharmaceuticals Corp., Vaxart, Inc

What are the Application segmentation covered in the Marburg Hemorrhagic Fever Drug Market report?

Ans: The Applications covered in the Marburg Hemorrhagic Fever Drug Market report are Clinic, Hospital, Others

What are the Type segmentation covered in the Marburg Hemorrhagic Fever Drug Market report?

Ans: The Types covered in the Marburg Hemorrhagic Fever Drug Market report are Marburg Vaccine, AVI-7288, TKM-Marburg, Others

1 Marburg Hemorrhagic Fever Drug Market Overview

1.1 Product Definition

1.2 Marburg Hemorrhagic Fever Drug by Type

1.2.1 Global Marburg Hemorrhagic Fever Drug Market Value Comparison by Type (2024 VS 2031)

1.2.2 Marburg Vaccine

1.2.3 AVI-7288

1.2.4 TKM-Marburg

1.2.5 Others

1.3 Marburg Hemorrhagic Fever Drug by Application

1.3.1 Global Marburg Hemorrhagic Fever Drug Market Value by Application (2024 VS 2031)

1.3.2 Clinic

1.3.3 Hospital

1.3.4 Others

1.4 Global Marburg Hemorrhagic Fever Drug Market Size Estimates and Forecasts

1.4.1 Global Marburg Hemorrhagic Fever Drug Revenue 2020-2031

1.4.2 Global Marburg Hemorrhagic Fever Drug Sales 2020-2031

1.4.3 Global Marburg Hemorrhagic Fever Drug Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Marburg Hemorrhagic Fever Drug Market Competition by Manufacturers

2.1 Global Marburg Hemorrhagic Fever Drug Sales Market Share by Manufacturers (2020-2025)

2.2 Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Marburg Hemorrhagic Fever Drug Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Marburg Hemorrhagic Fever Drug, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Marburg Hemorrhagic Fever Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Marburg Hemorrhagic Fever Drug, Product Type & Application

2.7 Global Key Manufacturers of Marburg Hemorrhagic Fever Drug, Date of Enter into This Industry

2.8 Global Marburg Hemorrhagic Fever Drug Market Competitive Situation and Trends

2.8.1 Global Marburg Hemorrhagic Fever Drug Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Marburg Hemorrhagic Fever Drug Players Market Share by Revenue

2.8.3 Global Marburg Hemorrhagic Fever Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Marburg Hemorrhagic Fever Drug Market Scenario by Region

3.1 Global Marburg Hemorrhagic Fever Drug Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Marburg Hemorrhagic Fever Drug Sales by Region: 2020-2031

3.2.1 Global Marburg Hemorrhagic Fever Drug Sales by Region: 2020-2025

3.2.2 Global Marburg Hemorrhagic Fever Drug Sales by Region: 2026-2031

3.3 Global Marburg Hemorrhagic Fever Drug Revenue by Region: 2020-2031

3.3.1 Global Marburg Hemorrhagic Fever Drug Revenue by Region: 2020-2025

3.3.2 Global Marburg Hemorrhagic Fever Drug Revenue by Region: 2026-2031

3.4 North America Marburg Hemorrhagic Fever Drug Market Facts & Figures by Country

3.4.1 North America Marburg Hemorrhagic Fever Drug Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Marburg Hemorrhagic Fever Drug Sales by Country (2020-2031)

3.4.3 North America Marburg Hemorrhagic Fever Drug Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Marburg Hemorrhagic Fever Drug Market Facts & Figures by Country

3.5.1 Europe Marburg Hemorrhagic Fever Drug Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Marburg Hemorrhagic Fever Drug Sales by Country (2020-2031)

3.5.3 Europe Marburg Hemorrhagic Fever Drug Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Marburg Hemorrhagic Fever Drug Market Facts & Figures by Region

3.6.1 Asia Pacific Marburg Hemorrhagic Fever Drug Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Marburg Hemorrhagic Fever Drug Sales by Region (2020-2031)

3.6.3 Asia Pacific Marburg Hemorrhagic Fever Drug Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Marburg Hemorrhagic Fever Drug Market Facts & Figures by Country

3.7.1 Latin America Marburg Hemorrhagic Fever Drug Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Marburg Hemorrhagic Fever Drug Sales by Country (2020-2031)

3.7.3 Latin America Marburg Hemorrhagic Fever Drug Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Marburg Hemorrhagic Fever Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Marburg Hemorrhagic Fever Drug Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Marburg Hemorrhagic Fever Drug Sales by Country (2020-2031)

3.8.3 Middle East and Africa Marburg Hemorrhagic Fever Drug Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Marburg Hemorrhagic Fever Drug Sales by Type (2020-2031)

4.1.1 Global Marburg Hemorrhagic Fever Drug Sales by Type (2020-2025)

4.1.2 Global Marburg Hemorrhagic Fever Drug Sales by Type (2026-2031)

4.1.3 Global Marburg Hemorrhagic Fever Drug Sales Market Share by Type (2020-2031)

4.2 Global Marburg Hemorrhagic Fever Drug Revenue by Type (2020-2031)

4.2.1 Global Marburg Hemorrhagic Fever Drug Revenue by Type (2020-2025)

4.2.2 Global Marburg Hemorrhagic Fever Drug Revenue by Type (2026-2031)

4.2.3 Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Type (2020-2031)

4.3 Global Marburg Hemorrhagic Fever Drug Price by Type (2020-2031)

5 Segment by Application

5.1 Global Marburg Hemorrhagic Fever Drug Sales by Application (2020-2031)

5.1.1 Global Marburg Hemorrhagic Fever Drug Sales by Application (2020-2025)

5.1.2 Global Marburg Hemorrhagic Fever Drug Sales by Application (2026-2031)

5.1.3 Global Marburg Hemorrhagic Fever Drug Sales Market Share by Application (2020-2031)

5.2 Global Marburg Hemorrhagic Fever Drug Revenue by Application (2020-2031)

5.2.1 Global Marburg Hemorrhagic Fever Drug Revenue by Application (2020-2025)

5.2.2 Global Marburg Hemorrhagic Fever Drug Revenue by Application (2026-2031)

5.2.3 Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Application (2020-2031)

5.3 Global Marburg Hemorrhagic Fever Drug Price by Application (2020-2031)

6 Key Companies Profiled

6.1 GlaxoSmithKline plc

6.1.1 GlaxoSmithKline plc Company Information

6.1.2 GlaxoSmithKline plc Description and Business Overview

6.1.3 GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Sales, Revenue and Gross Margin (2020-2025)

6.1.4 GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Product Portfolio

6.1.5 GlaxoSmithKline plc Recent Developments/Updates

6.2 Immunovaccine, Inc.

6.2.1 Immunovaccine, Inc. Company Information

6.2.2 Immunovaccine, Inc. Description and Business Overview

6.2.3 Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio

6.2.5 Immunovaccine, Inc. Recent Developments/Updates

6.3 Integrated BioTherapeutics, Inc.

6.3.1 Integrated BioTherapeutics, Inc. Company Information

6.3.2 Integrated BioTherapeutics, Inc. Description and Business Overview

6.3.3 Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio

6.3.5 Integrated BioTherapeutics, Inc. Recent Developments/Updates

6.4 Sarepta Therapeutics, Inc.

6.4.1 Sarepta Therapeutics, Inc. Company Information

6.4.2 Sarepta Therapeutics, Inc. Description and Business Overview

6.4.3 Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Product Portfolio

6.4.5 Sarepta Therapeutics, Inc. Recent Developments/Updates

6.5 Tekmira Pharmaceuticals Corp.

6.5.1 Tekmira Pharmaceuticals Corp. Company Information

6.5.2 Tekmira Pharmaceuticals Corp. Description and Business Overview

6.5.3 Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Product Portfolio

6.5.5 Tekmira Pharmaceuticals Corp. Recent Developments/Updates

6.6 Vaxart, Inc

6.6.1 Vaxart, Inc Company Information

6.6.2 Vaxart, Inc Description and Business Overview

6.6.3 Vaxart, Inc Marburg Hemorrhagic Fever Drug Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Vaxart, Inc Marburg Hemorrhagic Fever Drug Product Portfolio

6.6.5 Vaxart, Inc Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Marburg Hemorrhagic Fever Drug Industry Chain Analysis

7.2 Marburg Hemorrhagic Fever Drug Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Marburg Hemorrhagic Fever Drug Production Mode & Process Analysis

7.4 Marburg Hemorrhagic Fever Drug Sales and Marketing

7.4.1 Marburg Hemorrhagic Fever Drug Sales Channels

7.4.2 Marburg Hemorrhagic Fever Drug Distributors

7.5 Marburg Hemorrhagic Fever Drug Customer Analysis

8 Marburg Hemorrhagic Fever Drug Market Dynamics

8.1 Marburg Hemorrhagic Fever Drug Industry Trends

8.2 Marburg Hemorrhagic Fever Drug Market Drivers

8.3 Marburg Hemorrhagic Fever Drug Market Challenges

8.4 Marburg Hemorrhagic Fever Drug Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

GlaxoSmithKline PLC

Immunovaccine

Integrated BioTherapeutics Inc

Sarepta Therapeutics Inc

Tekmira Pharmaceuticals Corp.

Vaxart Inc.

List of Tables

Table 1. Global Marburg Hemorrhagic Fever Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Marburg Hemorrhagic Fever Drug Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Marburg Hemorrhagic Fever Drug Market Competitive Situation by Manufacturers in 2024

Table 4. Global Marburg Hemorrhagic Fever Drug Sales (K Pcs) of Key Manufacturers (2020-2025)

Table 5. Global Marburg Hemorrhagic Fever Drug Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Marburg Hemorrhagic Fever Drug Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Marburg Hemorrhagic Fever Drug Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Marburg Hemorrhagic Fever Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Marburg Hemorrhagic Fever Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Marburg Hemorrhagic Fever Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Marburg Hemorrhagic Fever Drug, Product Type & Application

Table 12. Global Key Manufacturers of Marburg Hemorrhagic Fever Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Marburg Hemorrhagic Fever Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Marburg Hemorrhagic Fever Drug as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Marburg Hemorrhagic Fever Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Marburg Hemorrhagic Fever Drug Sales by Region (2020-2025) & (K Pcs)

Table 18. Global Marburg Hemorrhagic Fever Drug Sales Market Share by Region (2020-2025)

Table 19. Global Marburg Hemorrhagic Fever Drug Sales by Region (2026-2031) & (K Pcs)

Table 20. Global Marburg Hemorrhagic Fever Drug Sales Market Share by Region (2026-2031)

Table 21. Global Marburg Hemorrhagic Fever Drug Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Region (2020-2025)

Table 23. Global Marburg Hemorrhagic Fever Drug Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Region (2026-2031)

Table 25. North America Marburg Hemorrhagic Fever Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Marburg Hemorrhagic Fever Drug Sales by Country (2020-2025) & (K Pcs)

Table 27. North America Marburg Hemorrhagic Fever Drug Sales by Country (2026-2031) & (K Pcs)

Table 28. North America Marburg Hemorrhagic Fever Drug Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Marburg Hemorrhagic Fever Drug Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Marburg Hemorrhagic Fever Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Marburg Hemorrhagic Fever Drug Sales by Country (2020-2025) & (K Pcs)

Table 32. Europe Marburg Hemorrhagic Fever Drug Sales by Country (2026-2031) & (K Pcs)

Table 33. Europe Marburg Hemorrhagic Fever Drug Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Marburg Hemorrhagic Fever Drug Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Marburg Hemorrhagic Fever Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Marburg Hemorrhagic Fever Drug Sales by Region (2020-2025) & (K Pcs)

Table 37. Asia Pacific Marburg Hemorrhagic Fever Drug Sales by Region (2026-2031) & (K Pcs)

Table 38. Asia Pacific Marburg Hemorrhagic Fever Drug Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Marburg Hemorrhagic Fever Drug Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Marburg Hemorrhagic Fever Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Marburg Hemorrhagic Fever Drug Sales by Country (2020-2025) & (K Pcs)

Table 42. Latin America Marburg Hemorrhagic Fever Drug Sales by Country (2026-2031) & (K Pcs)

Table 43. Latin America Marburg Hemorrhagic Fever Drug Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Marburg Hemorrhagic Fever Drug Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Marburg Hemorrhagic Fever Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Marburg Hemorrhagic Fever Drug Sales by Country (2020-2025) & (K Pcs)

Table 47. Middle East and Africa Marburg Hemorrhagic Fever Drug Sales by Country (2026-2031) & (K Pcs)

Table 48. Middle East and Africa Marburg Hemorrhagic Fever Drug Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Marburg Hemorrhagic Fever Drug Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Marburg Hemorrhagic Fever Drug Sales (K Pcs) by Type (2020-2025)

Table 51. Global Marburg Hemorrhagic Fever Drug Sales (K Pcs) by Type (2026-2031)

Table 52. Global Marburg Hemorrhagic Fever Drug Sales Market Share by Type (2020-2025)

Table 53. Global Marburg Hemorrhagic Fever Drug Sales Market Share by Type (2026-2031)

Table 54. Global Marburg Hemorrhagic Fever Drug Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Marburg Hemorrhagic Fever Drug Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Type (2020-2025)

Table 57. Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Type (2026-2031)

Table 58. Global Marburg Hemorrhagic Fever Drug Price (USD/Pcs) by Type (2020-2025)

Table 59. Global Marburg Hemorrhagic Fever Drug Price (USD/Pcs) by Type (2026-2031)

Table 60. Global Marburg Hemorrhagic Fever Drug Sales (K Pcs) by Application (2020-2025)

Table 61. Global Marburg Hemorrhagic Fever Drug Sales (K Pcs) by Application (2026-2031)

Table 62. Global Marburg Hemorrhagic Fever Drug Sales Market Share by Application (2020-2025)

Table 63. Global Marburg Hemorrhagic Fever Drug Sales Market Share by Application (2026-2031)

Table 64. Global Marburg Hemorrhagic Fever Drug Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Marburg Hemorrhagic Fever Drug Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Application (2020-2025)

Table 67. Global Marburg Hemorrhagic Fever Drug Revenue Market Share by Application (2026-2031)

Table 68. Global Marburg Hemorrhagic Fever Drug Price (USD/Pcs) by Application (2020-2025)

Table 69. Global Marburg Hemorrhagic Fever Drug Price (USD/Pcs) by Application (2026-2031)

Table 70. GlaxoSmithKline plc Company Information

Table 71. GlaxoSmithKline plc Description and Business Overview

Table 72. GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 73. GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Product

Table 74. GlaxoSmithKline plc Recent Developments/Updates

Table 75. Immunovaccine, Inc. Company Information

Table 76. Immunovaccine, Inc. Description and Business Overview

Table 77. Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 78. Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Product

Table 79. Immunovaccine, Inc. Recent Developments/Updates

Table 80. Integrated BioTherapeutics, Inc. Company Information

Table 81. Integrated BioTherapeutics, Inc. Description and Business Overview

Table 82. Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 83. Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Product

Table 84. Integrated BioTherapeutics, Inc. Recent Developments/Updates

Table 85. Sarepta Therapeutics, Inc. Company Information

Table 86. Sarepta Therapeutics, Inc. Description and Business Overview

Table 87. Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 88. Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Product

Table 89. Sarepta Therapeutics, Inc. Recent Developments/Updates

Table 90. Tekmira Pharmaceuticals Corp. Company Information

Table 91. Tekmira Pharmaceuticals Corp. Description and Business Overview

Table 92. Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 93. Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Product

Table 94. Tekmira Pharmaceuticals Corp. Recent Developments/Updates

Table 95. Vaxart, Inc Company Information

Table 96. Vaxart, Inc Description and Business Overview

Table 97. Vaxart, Inc Marburg Hemorrhagic Fever Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 98. Vaxart, Inc Marburg Hemorrhagic Fever Drug Product

Table 99. Vaxart, Inc Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Marburg Hemorrhagic Fever Drug Distributors List

Table 103. Marburg Hemorrhagic Fever Drug Customers List

Table 104. Marburg Hemorrhagic Fever Drug Market Trends

Table 105. Marburg Hemorrhagic Fever Drug Market Drivers

Table 106. Marburg Hemorrhagic Fever Drug Market Challenges

Table 107. Marburg Hemorrhagic Fever Drug Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of Marburg Hemorrhagic Fever Drug

Figure 2. Global Marburg Hemorrhagic Fever Drug Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Marburg Hemorrhagic Fever Drug Market Share by Type: 2024 & 2031

Figure 4. Marburg Vaccine Product Picture

Figure 5. AVI-7288 Product Picture

Figure 6. TKM-Marburg Product Picture

Figure 7. Others Product Picture

Figure 8. Global Marburg Hemorrhagic Fever Drug Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Marburg Hemorrhagic Fever Drug Market Share by Application: 2024 & 2031

Figure 10. Clinic

Figure 11. Hospital

Figure 12. Others

Figure 13. Global Marburg Hemorrhagic Fever Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Marburg Hemorrhagic Fever Drug Market Size (2020-2031) & (US$ Million)

Figure 15. Global Marburg Hemorrhagic Fever Drug Sales (2020-2031) & (K Pcs)

Figure 16. Global Marburg Hemorrhagic Fever Drug Average Price (USD/Pcs) & (2020-2031)

Figure 17. Marburg Hemorrhagic Fever Drug Report Years Considered

Figure 18. Marburg Hemorrhagic Fever Drug Sales Share by Manufacturers in 2024

Figure 19. Global Marburg Hemorrhagic Fever Drug Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Marburg Hemorrhagic Fever Drug Players: Market Share by Revenue in Marburg Hemorrhagic Fever Drug in 2024

Figure 21. Marburg Hemorrhagic Fever Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Marburg Hemorrhagic Fever Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Marburg Hemorrhagic Fever Drug Sales Market Share by Country (2020-2031)

Figure 24. North America Marburg Hemorrhagic Fever Drug Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Marburg Hemorrhagic Fever Drug Sales Market Share by Country (2020-2031)

Figure 28. Europe Marburg Hemorrhagic Fever Drug Revenue Market Share by Country (2020-2031)

Figure 29. Germany Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Marburg Hemorrhagic Fever Drug Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Marburg Hemorrhagic Fever Drug Revenue Market Share by Region (2020-2031)

Figure 36. China Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Marburg Hemorrhagic Fever Drug Sales Market Share by Country (2020-2031)

Figure 47. Latin America Marburg Hemorrhagic Fever Drug Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Marburg Hemorrhagic Fever Drug Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Marburg Hemorrhagic Fever Drug Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. UAE Marburg Hemorrhagic Fever Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Marburg Hemorrhagic Fever Drug by Type (2020-2031)

Figure 57. Global Revenue Market Share of Marburg Hemorrhagic Fever Drug by Type (2020-2031)

Figure 58. Global Marburg Hemorrhagic Fever Drug Price (USD/Pcs) by Type (2020-2031)

Figure 59. Global Sales Market Share of Marburg Hemorrhagic Fever Drug by Application (2020-2031)

Figure 60. Global Revenue Market Share of Marburg Hemorrhagic Fever Drug by Application (2020-2031)

Figure 61. Global Marburg Hemorrhagic Fever Drug Price (USD/Pcs) by Application (2020-2031)

Figure 62. Marburg Hemorrhagic Fever Drug Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions